Protocol Details

Evaluation and Treatment of Subjects with Dermatologic Diseases

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number	96-AR-0102
Sponsoring Institute	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruitment Detail	Type: Participants currently recruited/enrolled Gender: Male & Female Min Age: N/A Max Age: N/A
Referral Letter Required	No
Population Exclusion(s)	None
Keywords	Natural History; Consultation; Standard Therapy; Standard Tests; Training; Natural History
Recruitment Keyword(s)	None
Condition(s)	Dermatologic Diseases; Systemic Diseases with Cutaneous Manifestations
Investigational Drug(s)	None
Investigational Device(s)	None
Intervention(s)	None
Supporting Site	National Institute of Arthritis and Musculoskeletal and Skin Diseases

This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Patients of any age (only viable neonates will enroll in the study), of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations that will help the Branch fulfill the objectives.

Women who are pregnant or lactating, will only undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus and/or child.

Patients must have a referring physician who will continue to assume primary medical responsibility of care for the patient during and after enrollment in this protocol.

EXCLUSION CRITERIA:

Any participant who, in the investigator s opinion, would be unable to comply with study requirements or for whom participation may pose a greater medical risk.

--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator	Referral Contact	For more information:
Edward W. Cowen, M.D. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIHBC 10 - CLINICAL CENTER BG RM 12N240A 10 CENTER DR BETHESDA MD 20892 (301) 827-2328 ec176r@nih.gov	Kelli A. Karacki, P.A.-C National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIHBC 10 - CLINICAL CENTER BG RM 12N240 10 CENTER DR BETHESDA MD 20892 (301) 402-7806 kelli.karacki@nih.gov	NCI Referral Office National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office 1-888-NCI-1937

Clinical Trials Number:

NCT00001506

--Back to Top--